ANALYSIS OF A RANGE OF ABDOMINAL AND BOWEL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA REPORTING INADEQUATE SYMPTOM CONTROL WITH LOPERAMIDE: RESULTS FROM ELUXADOLINE CLINICAL TRIALS

被引：0
|
作者：
Brenner, Darren M.
Sayuk, Gregory S.
Saeed, Mazen
Janiszewski, Peter
Liu, Louis W.
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1327
引用
收藏
页码：S851 / S851
页数：1
相关论文
共 50 条
  • [11] Eluxadoline Demonstrates Sustained Efficacy for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome in Phase 3 Clinical Trials
    Chey, William D.
    Dove, Scott
    Andrae, David
    Davenport, J. Michael
    Turner, Lisa
    Lopez, Rocio
    Covington, Paul S.
    GASTROENTEROLOGY, 2015, 148 (04) : S70 - S71
  • [12] UNDERSTANDING SYMPTOM BURDEN AND ATTITUDES IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA: RESULTS FROM A PATIENT SURVEY
    Tornblom, Hans
    Emmanuel, Anton
    Goosey, Richard
    Wiseman, Gwen
    Baker, Stephen
    GASTROENTEROLOGY, 2017, 152 (05) : S745 - S746
  • [13] Robustness of Eluxadoline for the Treatment of Irritable Bowel Syndrome With Diarrhea: Results From Phase 3 Composite Endpoint Assessments
    Lacy, Brian E.
    Dove, Scott
    Andrae, David
    Davenport, J. Michael
    Turner, Lisa
    Lopez, Rocio
    Covington, Paul S.
    GASTROENTEROLOGY, 2015, 148 (04) : S491 - S491
  • [14] Inadequate safety reporting in the publications of randomised clinical trials in irritable bowel syndrome: drug versus probiotic interventions
    van der Geest, A. M.
    Schukking, I
    Brummer, R. J. M.
    Pieterse, H.
    van den Nieuwboer, M.
    van de Burgwal, L. H. M.
    Larsen, O. F. A.
    BENEFICIAL MICROBES, 2022, 13 (03) : 195 - 204
  • [15] A Low FODMAP Diet Reduces Abdominal Symptoms to a Greater Degree Than Bowel Symptoms in Patients With Irritable Bowel Syndrome and Diarrhea: Results of Daily Data From a US Randomized Controlled Trial
    Eswaran, Shanti L.
    Chey, William D.
    Jackson, Kenya
    Ball, Sarah
    Han-Markey, Theresa
    GASTROENTEROLOGY, 2016, 150 (04) : S229 - S230
  • [16] Assessing Abdominal and Bowel Symptoms Using Adequate Relief Based Thresholds: Results From 2 Phase 3 Trials of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
    Camilleri, Michael
    Lembo, Anthony
    Lavins, Bernard J.
    MacDougall, James E.
    Shiff, Steven J.
    Jia, Xinwei D.
    Currie, Mark G.
    Kurtz, Caroline B.
    Johnston, Jeffrey M.
    GASTROENTEROLOGY, 2013, 144 (05) : S728 - S729
  • [17] RIFAXIMIN AND ELUXADOLINE UTILIZATION FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN THE UNITED STATES AND BUDGET IMPACT ANALYSIS OF SWITCHING FROM ELUXADOLINE TO RIFAXIMIN
    Bloudek, L. M.
    Bozkaya, D.
    O'Hara, K.
    Kirby, S. K.
    Shah, S.
    VALUE IN HEALTH, 2018, 21 : S83 - S83
  • [18] Age Differences in Core Symptoms and Symptom Relationships in Patients With Irritable Bowel Syndrome: A Network Analysis
    Yang, Pei-Lin
    Kamp, Kendra J.
    Burr, Robert L.
    Tang, Hsin-Yi
    Dobra, Adrian
    Shulman, Robert J.
    Heitkemper, Margaret M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (09): : 1648 - 1655
  • [19] AGE DIFFERENCES IN CORE SYMPTOMS AND SYMPTOM RELATIONSHIPS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A NETWORK ANALYSIS
    Yang, Pei-Lin
    Kamp, Kendra
    Burr, Robert
    Tang, Hsin-Yi
    Dobra, Adrian
    Heitkemper, Margaret
    GASTROENTEROLOGY, 2023, 164 (06) : S758 - S758
  • [20] Effect of Alosetron on Bowel Urgency and Global Symptoms in Women With Severe, Diarrhea-Predominant Irritable Bowel Syndrome: Analysis of Two Controlled Trials
    Lembo, Anthony J.
    Olden, Kevin W.
    Ameen, Vanessa Z.
    Gordon, Susan L.
    Heath, Amy T.
    Carter, Eric G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (08) : 675 - 682
12345